Blood clots have long been implicated in heart attacks and strokes. While the role of one key protein, called von Willebrand factor, has been established, a reliable model for predicting how it collects in blood vessels remains elusive. Researchers review recent work on understanding the behavior of vWF in APL Bioengineering, painting a portrait of vWF, and by highlighting advances in the field, the authors put forth promising avenues for therapies in controlling these proteins.Article Correctness Is Author's Responsibility: Laying Out Directions for Future of Reliable Blood Clotting Molecule Models
Blood clots have long been implicated in heart attacks and strokes. While the role of one key protein, called von Willebrand factor, has been established, a reliable model for predicting how it collects in blood vessels remains elusive. Researchers review recent work on understanding the behavior of vWF in APL Bioengineering, painting a portrait of vWF, and by highlighting advances in the field, the authors put forth promising avenues for therapies in controlling these proteins.
